Tempus AI (NASDAQ:TEM) CAO Ryan Bartolucci Sells 4,116 Shares

Tempus AI, Inc. (NASDAQ:TEM) CAO Ryan Bartolucci sold 4,116 shares of the stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $44.07, for a total transaction of $181,392.12. Following the transaction, the chief accounting officer directly owned 74,041 shares of the company’s stock, valued at $3,262,986.87. This trade represents a 5.27% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Tempus AI Trading Up 1.3%

Shares of Tempus AI stock opened at $46.49 on Friday. Tempus AI, Inc. has a twelve month low of $41.73 and a twelve month high of $104.32. The company has a quick ratio of 3.15, a current ratio of 3.31 and a debt-to-equity ratio of 2.96. The business has a 50-day moving average price of $49.02 and a 200-day moving average price of $59.39. The firm has a market cap of $8.35 billion, a price-to-earnings ratio of -27.03 and a beta of 3.99.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings results on Tuesday, May 5th. The company reported ($0.13) EPS for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.08. The company had revenue of $348.12 million during the quarter, compared to analyst estimates of $345.44 million. Tempus AI had a negative return on equity of 53.83% and a negative net margin of 22.20%.The firm’s revenue was up 36.1% on a year-over-year basis. During the same period in the prior year, the company earned ($0.24) earnings per share. Equities research analysts anticipate that Tempus AI, Inc. will post -1.35 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Guggenheim cut their target price on shares of Tempus AI from $95.00 to $60.00 and set a “buy” rating for the company in a report on Monday, March 30th. Wall Street Zen downgraded shares of Tempus AI from a “hold” rating to a “sell” rating in a research note on Saturday, February 28th. Stifel Nicolaus set a $60.00 price objective on shares of Tempus AI in a research note on Wednesday, February 25th. Mizuho started coverage on shares of Tempus AI in a report on Thursday, February 19th. They issued an “outperform” rating and a $100.00 target price on the stock. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Tempus AI in a research report on Thursday, January 22nd. Nine investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $68.64.

Institutional Trading of Tempus AI

A number of institutional investors have recently bought and sold shares of TEM. Silverback Asset Management LLC boosted its stake in Tempus AI by 44.5% during the first quarter. Silverback Asset Management LLC now owns 35,700 shares of the company’s stock worth $1,614,000 after buying an additional 11,000 shares during the period. Vestor Capital LLC raised its stake in shares of Tempus AI by 338.2% in the first quarter. Vestor Capital LLC now owns 1,538 shares of the company’s stock valued at $70,000 after acquiring an additional 1,187 shares during the period. Arkadios Wealth Advisors lifted its holdings in shares of Tempus AI by 9.6% in the 1st quarter. Arkadios Wealth Advisors now owns 4,963 shares of the company’s stock worth $224,000 after acquiring an additional 435 shares during the last quarter. Amundi boosted its stake in shares of Tempus AI by 30.4% during the 1st quarter. Amundi now owns 18,959 shares of the company’s stock worth $857,000 after purchasing an additional 4,417 shares during the period. Finally, California State Teachers Retirement System boosted its stake in shares of Tempus AI by 23.1% during the 1st quarter. California State Teachers Retirement System now owns 107,686 shares of the company’s stock worth $4,870,000 after purchasing an additional 20,182 shares during the period. 24.22% of the stock is currently owned by institutional investors.

About Tempus AI

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.